On the public citation graph

A New Drug Combinatory Effect Prediction Algorithm on the Cancer Cell Based on Gene Expression and Dose–Response Curve

0 signed · 67 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-3-642-28951-4_6openalex-snapshot
Prevention of Drug Resistance by Combined Drug Treatment of Tuberculosis
inferredcites →https://doi.org/10.1007/bf02821337openalex-snapshot
The European Bioinformatics Institute
inferredcites →https://doi.org/10.1016/j.phymed.2013.07.015openalex-snapshot
Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down?
inferredcites →https://doi.org/10.1038/nature11005openalex-snapshot
Systematic identification of genomic markers of drug sensitivity in cancer cells
inferredcites →https://doi.org/10.1038/nbt.2284openalex-snapshot
Combinatorial drug therapy for cancer in the post-genomic era
inferredcites →https://doi.org/10.1038/nrd2683openalex-snapshot
Mechanisms of drug combinations: interaction and network perspectives
inferredcites →https://doi.org/10.1038/nrm2041openalex-snapshot
Data-driven modelling of signal-transduction networks
inferredcites →https://doi.org/10.1038/scibx.2013.4openalex-snapshot
Scaling up iPS cells
inferredcites →https://doi.org/10.1039/c4mb00014eopenalex-snapshot
Pathway-based Bayesian inference of drug–disease interactions
inferredcites →https://doi.org/10.1046/j.1469-0691.2000.00149.xopenalex-snapshot
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents
inferredcites →https://doi.org/10.1073/pnas.1018854108openalex-snapshot
Subtype and pathway specific responses to anticancer compounds in breast cancer
inferredcites →https://doi.org/10.1073/pnas.1337088100openalex-snapshot
Systematic discovery of multicomponent therapeutics
inferredcites →https://doi.org/10.1098/rstb.2005.1810openalex-snapshot
Rigorous performance evaluation in protein structure modelling and implications for computational biology
inferredcites →https://doi.org/10.1124/dmd.104.002717openalex-snapshot
A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
inferredcites →https://doi.org/10.1126/scitranslmed.3006667openalex-snapshot
High-Throughput Methods for Combinatorial Drug Discovery
inferredcites →https://doi.org/10.1136/amiajnl-2013-002512openalex-snapshot
Machine learning-based prediction of drug–drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties
inferredcites →https://doi.org/10.1158/0008-5472.can-06-4495openalex-snapshot
Bexarotene (LGD1069, Targretin), a Selective Retinoid X Receptor Agonist, Prevents and Reverses Gemcitabine Resistance in NSCLC Cells by Modulating Gene Amplification
inferredcites →https://doi.org/10.1182/blood-2010-05-282780openalex-snapshot
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
inferredcites →https://doi.org/10.1371/journal.pcbi.1000249openalex-snapshot
Search Algorithms as a Framework for the Optimization of Drug Combinations
inferredcites →https://doi.org/10.1371/journal.pcbi.1002323openalex-snapshot
Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data
inferredcites →https://doi.org/10.1371/journal.pone.0009202openalex-snapshot
Towards a Rigorous Assessment of Systems Biology Models: The DREAM3 Challenges
inferredcites →https://doi.org/10.1371/journal.pone.0101183openalex-snapshot
An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge
inferredcites →https://doi.org/10.2174/138945011793591626openalex-snapshot
Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
inferredcites →https://doi.org/10.2174/18715206113139990141openalex-snapshot
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/psp4.12004openalex-snapshot
Database: A New Article Type in CPT: Pharmacometrics & Systems Pharmacology
inferred← citeshttps://doi.org/10.1007/s00109-023-02414-4openalex-snapshot
FDA-approved disulfiram as a novel treatment for aggressive leukemia
inferred← citeshttps://doi.org/10.1007/s11831-021-09617-3openalex-snapshot
A Comprehensive Review on Deep Synergistic Drug Prediction Techniques for Cancer
inferred← citeshttps://doi.org/10.1016/j.artmed.2017.05.008openalex-snapshot
Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105334openalex-snapshot
Artificial intelligence techniques for prediction of drug synergy in malignant diseases: Past, present, and future
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.110788openalex-snapshot
Precision oncology informatics for anticancer drug combination responses: A systematic review
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.07.003openalex-snapshot
Machine learning in the prediction of cancer therapy
inferred← citeshttps://doi.org/10.1016/j.csbj.2024.12.003openalex-snapshot
Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations
inferred← citeshttps://doi.org/10.1016/j.phrs.2021.105617openalex-snapshot
A multi-herb-combined remedy to overcome hyper-inflammatory response by reprogramming transcription factor profile and shaping monocyte subsets
inferred← citeshttps://doi.org/10.1016/j.xcrm.2020.100037openalex-snapshot
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo
inferred← citeshttps://doi.org/10.1038/s41416-021-01332-xopenalex-snapshot
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin
inferred← citeshttps://doi.org/10.1093/bib/bbac302openalex-snapshot
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
inferred← citeshttps://doi.org/10.1093/bib/bbad346openalex-snapshot
COIMMR: a computational framework to reveal the contribution of herbal ingredients against human cancer via immune microenvironment and metabolic reprogramming
inferred← citeshttps://doi.org/10.1093/bioadv/vbaf092openalex-snapshot
SynDRep: a synergistic partner prediction tool based on knowledge graph for drug repurposing
inferred← citeshttps://doi.org/10.1093/bioadv/vbag051openalex-snapshot
CDCR-Rank: a computational model for predicting drug combination dose response using ranking-based optimization
inferred← citeshttps://doi.org/10.1093/bioinformatics/btae604openalex-snapshot
Dual-view jointly learning improves personalized drug synergy prediction
inferred← citeshttps://doi.org/10.1093/bioinformatics/btae750openalex-snapshot
Heterogeneous entity representation for medicinal synergy prediction
inferred← citeshttps://doi.org/10.1093/bioinformatics/btw509openalex-snapshot
Predicting synergistic effects between compounds through their structural similarity and effects on transcriptomes
inferred← citeshttps://doi.org/10.1093/bioinformatics/btx806openalex-snapshot
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
inferred← citeshttps://doi.org/10.1093/bioinformatics/bty860openalex-snapshot
DIGREM: an integrated web-based platform for detecting effective multi-drug combinations
inferred← citeshttps://doi.org/10.1093/jamia/ocaa212openalex-snapshot
Anticancer drug synergy prediction in understudied tissues using transfer learning
inferred← citeshttps://doi.org/10.1101/2021.06.28.450165openalex-snapshot
Logical modeling: Combining manual curation and automated parameterization to predict drug synergies
inferred← citeshttps://doi.org/10.1109/bigdataservice70481.2026.00023openalex-snapshot
SYNAPX: Explainable Anticancer Drug Synergy Prediction via SHAP Analysis
inferred← citeshttps://doi.org/10.1109/ijcnn64981.2025.11228264openalex-snapshot
AMHP-SDC: An Adaptive Semantic Meta-Graph and Hypergraph Learning Framework for Predicting Synergistic Drug Combinations
inferred← citeshttps://doi.org/10.1109/tnnls.2025.3553385openalex-snapshot
MRHGNN: Enhanced Multimodal Relational Hypergraph Neural Network for Synergistic Drug Combination Forecasting
inferred← citeshttps://doi.org/10.1128/jvi.00053-21openalex-snapshot
Using Split Luciferase Assay and Anti-Herpes Simplex Virus Glycoprotein Monoclonal Antibodies To Predict a Functional Binding Site between gD and gH/gL
inferred← citeshttps://doi.org/10.1155/2016/8518945openalex-snapshot
Biomolecular Network-Based Synergistic Drug Combination Discovery
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-20-0377openalex-snapshot
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways
inferred← citeshttps://doi.org/10.1186/s12859-023-05524-5openalex-snapshot
Predicting anticancer synergistic drug combinations based on multi-task learning
inferred← citeshttps://doi.org/10.1186/s12918-016-0310-3openalex-snapshot
A simple gene set-based method accurately predicts the synergy of drug pairs
inferred← citeshttps://doi.org/10.1186/s12943-017-0660-5openalex-snapshot
PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
inferred← citeshttps://doi.org/10.1186/s40246-022-00396-xopenalex-snapshot
A review of deep learning applications in human genomics using next-generation sequencing data
inferred← citeshttps://doi.org/10.18632/oncotarget.10446openalex-snapshot
A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia
inferred← citeshttps://doi.org/10.2174/1574892818666221018091415openalex-snapshot
Prediction of Cancer Treatment Using Advancements in Machine Learning
inferred← citeshttps://doi.org/10.3389/fonc.2021.711225openalex-snapshot
A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
inferred← citeshttps://doi.org/10.3389/fsysb.2023.1252961openalex-snapshot
Fine tuning a logical model of cancer cells to predict drug synergies: combining manual curation and automated parameterization
inferred← citeshttps://doi.org/10.3390/a9040077openalex-snapshot
Algorithms for Drug Sensitivity Prediction
inferred← citeshttps://doi.org/10.3390/ijms23179838openalex-snapshot
NEXGB: A Network Embedding Framework for Anticancer Drug Combination Prediction
inferred← citeshttps://doi.org/10.4172/jbb.1000248openalex-snapshot
Personalized Medicine: A Review with Regard to Biomarkers
inferred← citeshttps://doi.org/10.6084/m9.figshare.26645689openalex-snapshot
Additional file 1 of Predicting anticancer synergistic drug combinations based on multi-task learning
inferred← citeshttps://doi.org/10.6084/m9.figshare.26645692openalex-snapshot
Additional file 2 of Predicting anticancer synergistic drug combinations based on multi-task learning
inferred← citeshttps://doi.org/10.6084/m9.figshare.26645695openalex-snapshot
Additional file 3 of Predicting anticancer synergistic drug combinations based on multi-task learning
inferred← citeshttps://doi.org/10.7554/elife.52707openalex-snapshot
The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.